Brief: Acer Therapeutics Enters Into Extension Agreement With Mam Aardvark, Lenders
03/01/2023 14:15
Jan 3 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS INC - ON DECEMBER 30, 2022, CO ENTERED
INTO AN
EXTENSION AGREEMENT WITH MAM AARDVARK, LLC AND THE LENDERS
PARTY THERETO
* ACER THERAPEUTICS - EXTENSION AGREEMENT TO EXTEND LAST
DATE TO
REQUEST FUNDING BY LENDERS FROM DEC 31, 2022 TO JAN 16, 2023
Further company coverage: ACER.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31